Scientists claim Nobel Prize for approach behind light-activated gene therapy - Pharmaceutical Technology

The Nobel Prize committee says that optogenetics will lay the foundations for a new era in neuroscience, as pharma explores its role on treating ophthalmic conditions. The Nobel Prize committee says that optogenetics will lay the foundations for a new era in neuroscience, while pharma explores the method’s vision-restoring potential. Karl Diesseroth of Stanford University, Peter Hegemann of Berlin’s Humboldt University and Georg Nagel of the University of Würzburg will share the winnings for the 2026 Nobel Prize in Physiology or Medicine. Credit: AntonSAN / Shutterstock.com. A trio of German and American scientists have won this year’s Nobel Prize in…

Source: Pharmaceutical Technology